Advisory Services Network’s Dare Bioscience DARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,000
Closed -$5.04K 1600
2024
Q3
$5.04K Buy
15,000
+13,750
+1,100% +$47K ﹤0.01% 1524
2024
Q2
$5.04K Hold
1,250
﹤0.01% 1524
2024
Q1
$7.35K Hold
1,250
﹤0.01% 1451
2023
Q4
$4.63K Hold
1,250
﹤0.01% 3138
2023
Q3
$6.93K Hold
1,250
﹤0.01% 1468
2023
Q2
$13.7K Hold
1,250
﹤0.01% 1428
2023
Q1
$15.6K Hold
1,250
﹤0.01% 2685
2022
Q4
$12.4K Hold
1,250
﹤0.01% 2748
2022
Q3
$15K Sell
1,250
-167
-12% -$2.29K ﹤0.01% 1338
2022
Q2
$21K Buy
1,417
+167
+13% +$2.51K ﹤0.01% 1355
2022
Q1
$22K Buy
+1,250
New +$23.6K ﹤0.01% 1434

Other funds holding DARE

Advisory Services Network's DARE Position: Q4 2024 in Review

Advisory Services Network sold out of Dare Bioscience (DARE) in Q4 2024, closing a stake of 15,000 shares — an estimated $5.04K sold.

Advisory Services Network first reported a position in DARE in Q1 2022 and held it in 11 quarters. The position peaked at $22K in Q1 2022. 25 funds tracked by Wall St. Rank hold DARE as of Q4 2024.

  • Advisory Services Network reported no remaining Dare Bioscience position as of Q4 2024 after selling out during the quarter.
  • Advisory Services Network sold 15,000 Dare Bioscience shares in Q4 2024, an estimated $5.04K.
  • Advisory Services Network first reported a position in Dare Bioscience in Q1 2022 and held it in 11 quarters.
  • Advisory Services Network's Dare Bioscience position peaked at $22K in Q1 2022.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2024.

Based on Advisory Services Network's 13F filing for Q4 2024, filed 13 Feb 2025.